A 62-year-old man with multiple myeloma (IgG kappa) and a 55-year-old woman with light-chain myeloma (lambda) both present with renal dysfunction. Which finding best distinguishes the renal pathology between these two light-chain types?

Explanation

## Light-Chain Type and Renal Pathology in Multiple Myeloma ### Pathophysiology of Light-Chain Nephropathy **Key Point:** Lambda light chains are **significantly more nephrotoxic** than kappa light chains. Lambda chains are more prone to polymerization and aggregation in the renal tubule, leading to **cast nephropathy (myeloma kidney)** — the most common renal manifestation of light-chain myeloma. ### Comparison of Kappa vs. Lambda Nephrotoxicity | Feature | Kappa Light Chains | Lambda Light Chains | | --- | --- | --- | | **Nephrotoxicity** | Lower | **Higher (2–3× more toxic)** | | **Propensity to polymerize** | Low | **High** | | **Primary renal lesion** | Cast nephropathy (less common) | **Cast nephropathy (common)** | | **Glomerular involvement** | Rare | Possible (AL amyloidosis, light-chain deposition disease) | | **Frequency of renal failure** | ~20–30% | **~40–50%** | | **Reversibility with treatment** | Better | Poorer (fibrosis develops faster) | ### High-Yield Facts **High-Yield:** Lambda light-chain myeloma carries a **worse renal prognosis** than kappa. This is because: 1. Lambda chains have a higher isoelectric point and are more likely to precipitate in the acidic tubular environment. 2. Lambda chains form **casts more readily** in the distal tubule and collecting duct. 3. **Cast nephropathy** (myeloma kidney) is the hallmark renal lesion in light-chain myeloma, and lambda is the predominant culprit. ### Mechanism of Cast Nephropathy ```mermaid flowchart TD A[Light-chain overproduction]:::outcome --> B{Kappa or Lambda?}:::decision B -->|Kappa| C[Lower polymerization tendency]:::action B -->|Lambda| D[Higher polymerization tendency]:::action C --> E[Mild tubular injury, less cast formation]:::outcome D --> F[Rapid aggregation in distal tubule]:::action F --> G[Cast formation + tubular obstruction]:::outcome G --> H[Acute kidney injury, chronic renal failure]:::urgent ``` ### Clinical Pearl **Clinical Pearl:** A patient with light-chain myeloma and acute renal failure should be assumed to have **lambda light chains until proven otherwise**. Kappa light-chain disease is less likely to present with severe renal dysfunction. ### Mnemonic **Mnemonic:** **"Lambda = Lethal to kidneys"** — Lambda light chains are more likely to cause cast nephropathy and progressive renal failure in myeloma patients.